1. Stocks
    2. /
  2. Medibank Pvt Ltd (ASX: MPL)
    3. /

Medibank Pvt Ltd (ASX: MPL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Medibank Pvt Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $12.31 billion
P/E Ratio 24.73
Dividend Yield 4.00%
Shares Outstanding 2.75 billion
Earnings per share 0.182
Dividend per share 0.18
Year To Date Return N/A
Earnings Yield 4.04%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Medibank Pvt Ltd (ASX: MPL)
    Latest News

    Stethoscope with a piggy bank and hundred dollar notes.
    Dividend Investing

    Medibank shares: Here's the dividend yield you'll get today

    | Sebastian Bowen

    Medibank stock offers a decent dividend yield today.

    Read more »

    Two businessmen look out at the city from the top of a tall building.
    Broker Notes

    Buy or hold? Top broker rates these 2 ASX 200 shares

    | Zach Bristow

    One player stands out more than the other.

    Read more »

    A man looking at his laptop and thinking.
    Financial Shares

    Medibank shares dip as huge potential fines loom from 2022 data breach

    | Zach Bristow

    The regulator has stepped in on the case.

    Read more »

    Woman on her laptop thinking to herself.
    Healthcare Shares

    What is Goldman Sachs saying about Medibank shares in June?

    | James Mickleboro

    Let's see if the broker thinks that investors should be buying this private health insurer.

    Read more »

    a smiling woman holds up two fingers and winks.
    Dividend Investing

    Overinvested in CBA shares? Here are two alternative ASX dividend stocks

    | Tristan Harrison

    It could be smart to diversify with these passive income ideas.

    Read more »

    Woman with headphones on relaxing and looking at her phone happily.
    Dividend Investing

    Here's how I'd target a $2,000 second income by investing $35 a week

    | Tristan Harrison

    This would be my strategy to make investment income.

    Read more »

    A man with a wide, eager smile on his face holds up three fingers.
    Opinions

    Here are 3 reliable ASX shares I'd buy instead of the big four banks right now

    | Tristan Harrison

    I’m banking on these stocks to pay more reliable dividends than the financial sector.

    Read more »

    Person holding Australian dollar notes, symbolising dividends.
    Opinions

    With $1,000 to invest, should I buy ASX growth stocks or income shares?

    | Tristan Harrison

    Here’s my view on which investment Aussies should look at.

    Read more »

    an older man dressed in singlet wearing thick neck chains and a side turned cap holds up two fingers while operating DJ mixing equipment with a record player and headphones around his neck.
    Superannuation

    Why I'd buy high-yield ASX dividend shares for superannuation in retirement

    | Tristan Harrison

    High-yield ASX dividend shares can make a lot of sense in retirement.

    Read more »

    An older man throws his hands up in excitement as he rides a carnival swing high up in the air.
    Superannuation

    Top ASX shares to buy for your superannuation fund in May 2024

    | Motley Fool Staff

    Is your super working hard for you?

    Read more »

    Shot of a mature scientists working on a laptop in a lab.
    Healthcare Shares

    Down 10% since mid-March, are Medibank shares a buy or a sell?

    | Tristan Harrison

    Is this stock a healthy opportunity?

    Read more »

    An older couple hold hands as they bounce happily high in the air.
    Opinions

    3 ASX stocks to benefit from Australia's ageing population

    | Tristan Harrison

    Ageing demographies is a strong tailwind.

    Read more »

    Frequently Asked Questions

    Medibank Private was established by the Australian government in 1976 as a not-for-profit private health insurer. It converted into a for-profit entity in 2009 before listing on the ASX in November 2014.

    Yes, Medibank Private has paid dividends to shareholders every year since 2015. Typically, it pays an interim dividend in March and a final dividend in September, both fully franked.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    10 Sep 2025 $0.1020 100.00% Final 09 Oct 2025
    06 Mar 2025 $0.0780 100.00% Interim 26 Mar 2025
    04 Sep 2024 $0.0940 100.00% Final 26 Sep 2024
    29 Feb 2024 $0.0720 100.00% Interim 20 Mar 2024
    13 Sep 2023 $0.0830 100.00% Final 05 Oct 2023
    02 Mar 2023 $0.0630 100.00% Interim 22 Mar 2023
    07 Sep 2022 $0.0730 100.00% Final 29 Sep 2022
    04 Mar 2022 $0.0610 100.00% Interim 24 Mar 2022
    08 Sep 2021 $0.0690 100.00% Final 30 Sep 2021
    03 Mar 2021 $0.0580 100.00% Interim 25 Mar 2021
    02 Sep 2020 $0.0630 100.00% Final 24 Sep 2020
    03 Mar 2020 $0.0570 100.00% Interim 26 Mar 2020
    04 Sep 2019 $0.0740 100.00% Final 26 Sep 2019
    05 Mar 2019 $0.0570 100.00% Interim 28 Mar 2019
    05 Sep 2018 $0.0720 100.00% Final 27 Sep 2018
    06 Mar 2018 $0.0550 100.00% Interim 28 Mar 2018
    06 Sep 2017 $0.0000 100.00% Final 28 Sep 2017
    07 Mar 2017 $0.0525 100.00% Interim 29 Mar 2017
    06 Sep 2016 $0.0600 100.00% Final 28 Sep 2016
    04 Mar 2016 $0.0500 100.00% Interim 29 Mar 2016

    MPL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Medibank Pvt Ltd

    Previously owned by the Australian government, Medibank Private Ltd (ASX: MPL) is the largest health insurer in Australia.

    As of November 2022, its two brands, Medibank Private and ahm, provide cover to almost five million people.

    Medibank and Australia's fourth-largest health fund, NIB Holdings Limited (ASX: NIB), are the only health insurers listed on the ASX.

    In addition to private health insurance, the company provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.

    MPL Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    20 Feb 2026 $4.47 $-0.05 -1.11% 9,270,021 $4.48 $4.54 $4.45
    19 Feb 2026 $4.52 $-0.27 -5.64% 16,085,569 $4.60 $4.63 $4.45
    18 Feb 2026 $4.79 $0.27 5.97% 15,673,476 $4.58 $4.86 $4.58
    17 Feb 2026 $4.52 $0.02 0.44% 4,845,423 $4.49 $4.52 $4.47
    16 Feb 2026 $4.50 $0.02 0.45% 3,231,986 $4.47 $4.52 $4.45
    13 Feb 2026 $4.48 $0.00 0.00% 15,004,468 $4.47 $4.52 $4.44
    12 Feb 2026 $4.48 $-0.10 -2.18% 5,685,154 $4.59 $4.60 $4.46
    11 Feb 2026 $4.58 $0.02 0.44% 4,742,680 $4.57 $4.58 $4.50
    10 Feb 2026 $4.56 $-0.03 -0.65% 4,481,410 $4.60 $4.61 $4.53
    09 Feb 2026 $4.59 $0.02 0.44% 4,128,719 $4.58 $4.61 $4.56
    06 Feb 2026 $4.57 $-0.03 -0.65% 4,998,964 $4.59 $4.61 $4.53
    05 Feb 2026 $4.60 $-0.02 -0.43% 4,867,079 $4.62 $4.64 $4.59
    04 Feb 2026 $4.62 $-0.03 -0.65% 4,945,617 $4.62 $4.62 $4.55
    03 Feb 2026 $4.65 $0.00 0.00% 6,160,569 $4.64 $4.68 $4.63
    02 Feb 2026 $4.65 $0.03 0.65% 4,791,461 $4.63 $4.67 $4.61
    30 Jan 2026 $4.62 $0.00 0.00% 7,917,603 $4.65 $4.67 $4.58
    29 Jan 2026 $4.62 $-0.01 -0.22% 8,421,917 $4.62 $4.66 $4.58
    28 Jan 2026 $4.63 $0.07 1.54% 6,377,369 $4.56 $4.63 $4.53
    27 Jan 2026 $4.56 $0.01 0.22% 9,091,498 $4.48 $4.58 $4.48
    23 Jan 2026 $4.55 $-0.06 -1.30% 7,057,526 $4.58 $4.63 $4.54
    22 Jan 2026 $4.61 $-0.09 -1.91% 5,690,794 $4.71 $4.73 $4.61

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    23 Dec 2025 David Koczkar Transfer 535,832 $2,550,560
    Off-market transfer.
    23 Dec 2025 David Koczkar Transfer 535,832 $2,550,560
    Off-market transfer.
    12 Dec 2025 David Koczkar Issued 724,646 $3,398,589
    Issue of securities. 2,275,601 Performance Rights
    04 Sep 2025 David Koczkar Exercise 534,919 $2,685,293
    Conversion of securities. 1,779,810 Rights
    04 Sep 2025 David Koczkar Expiry 228,855 $1,148,852
    As advised by the company. lapsed Performance Rights. 1,550,955 Rights
    04 Sep 2025 David Koczkar Buy 535,832 $2,689,876
    Conversion of securities.
    01 Sep 2025 Jay Weatherill Buy 5,900 $30,031
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Michael (Mike) John Wilkins Non-Executive DirectorNon-Executive Chairman May 2017
    Mr Wilkins has more than 30 years of experience in financial services, predominantly in Australia and Asia. He is member of Investment and Capital Committee.
    Ms Kathryn Joy Fagg Non-Executive Director Mar 2022
    Ms Fagg is a director and Chair with several senior commercial and operational experience.
    Dr Lisa Margaret McIntyre Non-Executive Director Nov 2025
    --
    Ms Jacqueline Cherie Hey Non-Executive Director Nov 2025
    --
    Mr David Koczkar Chief Executive OfficerManaging Director May 2021
    Mr Koczkar has over 25 years of strategy, customer, commercial and operational experience across Australia, Asia and the UK, including previous work in the consulting and financial services industries.
    Mr Peter Dobie Everingham Non-Executive Director Mar 2022
    Mr Everingham has over 25 years of corporate experience in the digital sector, having held senior executive roles in that sector for 18 years. His senior leadership experience includes roles at companies with a consumer and technology focus. He is member of Investment and Capital Committee.
    Dr Tracey Leigh Batten Non-Executive Director Aug 2017
    Dr Batten has experience in the health services sector, with strong commercial, strategy and change leadership skills. She is also a member of the Risk Management Committee.
    Mr Gerard Dalbosco Non-Executive Director May 2021
    Mr Dalbosco was a partner of EY until September 2020, he held number of senior leadership roles including Oceania Managing Partner and CEO; Asia Pacific Joint Deputy CEO and Managing Partner-Markets; Oceania Managing Partner-Transaction Advisory Services; and Melbourne Managing Partner. Prior to these roles he advised organisations across a range of sectors in respect of merger and acquisitions advice, valuations, and strategic, commercial, and financial due diligence. He is also a member of Risk Management Committee.
    Ms Mei Ramsay Group General CounselCompany Secretary Mar 2011
    -
    Milosh Milisavljevic Chief Customer Officer
    -
    Mark Rogers Chief Financial Officer and Group Strategy
    -
    Tom Exton Chief Risk and Compliance Officer
    -
    Felicia Trewin Data and Technology
    -
    Mei Ramsay Group General CounselCompany Secretary
    -
    Rob Read Group Lead - Amplar Health
    -
    Kylie Bishop People Spaces and Sustainability
    -
    Meaghan Telford Policy Advocacy and Reputation
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 892,959,467 32.42%
    J P Morgan Nominees Australia Pty Limited 691,193,311 25.10%
    Citicorp Nominees Pty Limited 279,602,750 10.15%
    BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 53,403,629 1.94%
    BNP Paribas Noms Pty Ltd 52,018,924 1.89%
    National Nominees Limited 23,212,018 0.84%
    HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 19,787,507 0.72%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 10,400,458 0.38%
    HSBC Custody Nominees (Australia) Limited i 9,900,707 0.36%
    Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 9,459,352 0.34%
    Netwealth Investments Limited <Wrap Services A/C> 8,145,967 0.30%
    Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> 5,472,803 0.20%
    Ioof Investment Services Limited <Ips Superfund A/C> 4,651,005 0.17%
    HSBC Custody Nominees (Australia) Limited A/C 2 4,251,765 0.15%
    Bond Street Custodians Limited <Cockej F01832 A/C> 3,645,606 0.13%
    Netwealth Investments Limited <Super Services A/C> 3,474,013 0.13%
    Solium Nominees (Australia) Pty Ltd <Vsa A/C> 3,434,210 0.12%
    Ioof Investment Services Limited <Iisl Nal Isma 2 A/C> 3,413,362 0.12%
    BNP Paribas Noms (Nz) Ltd 3,358,180 0.12%
    Buttonwood Nominees Pty Ltd 3,007,154 0.12%

    Profile

    since

    Note